220 related articles for article (PubMed ID: 31807797)
1. [Severe SGLT-2 inhibitor-induced euglycemic ketoacidosis-a rare but serious complication].
Rotsel E; Pietsch U
Anaesthesist; 2020 Jan; 69(1):49-51. PubMed ID: 31807797
[TBL] [Abstract][Full Text] [Related]
2. SGLT-2 inhibitors and euglycemic diabetic ketoacidosis/diabetic ketoacidosis in FAERS: a pharmacovigilance assessment.
He Z; Lam K; Zhao W; Yang S; Li Y; Mo J; Gao S; Liang D; Qiu K; Huang M; Wu J
Acta Diabetol; 2023 Mar; 60(3):401-411. PubMed ID: 36576563
[TBL] [Abstract][Full Text] [Related]
3. Predisposing factors for the development of diabetic ketoacidosis with lower than anticipated glucose levels in type 2 diabetes patients on SGLT2-inhibitors: a review.
Bamgboye AO; Oni IO; Collier A
Eur J Clin Pharmacol; 2021 May; 77(5):651-657. PubMed ID: 33244632
[TBL] [Abstract][Full Text] [Related]
4. Sodium glucose co-transporter-2 inhibitor-induced diabetic ketoacidosis following tooth extraction: improving awareness among dental practitioners.
Yap SD; Hamblin PS; Bach L; Ekinci E; Wong R
Aust Dent J; 2021 Dec; 66(4):444-447. PubMed ID: 34432892
[TBL] [Abstract][Full Text] [Related]
5. [Diabetic euglycemic ketosis or ketoacidosis in individuals with type 2 diabetes treated by SGLT2 inhibitors: A series of Belgian clinical cases].
Menghoum N; Oriot P; Hermans MP; Mariage JL
Rev Med Interne; 2020 Apr; 41(4):226-231. PubMed ID: 31866073
[TBL] [Abstract][Full Text] [Related]
6. [Euglycemic ketoacidosis : a complication of SGLT2 inhibitors].
Mizuno A; Lolachi S; Pernet A
Rev Med Suisse; 2017 May; 13(565):1164-1167. PubMed ID: 28639760
[TBL] [Abstract][Full Text] [Related]
7. Severe euglycemic diabetic ketoacidosis of multifactorial etiology in a type 2 diabetic patient treated with empagliflozin: case report and literature review.
Sampani E; Sarafidis P; Dimitriadis C; Kasimatis E; Daikidou D; Bantis K; Papanikolaou A; Papagianni A
BMC Nephrol; 2020 Jul; 21(1):276. PubMed ID: 32669085
[TBL] [Abstract][Full Text] [Related]
8. Treatment of a Severe Form of Euglycemic Ketoacidosis in a Patient Treated with SGLT-2 Inhibitors with the Aid of Somatostatin.
Torre A; Bisogno N; Botta C; Caiazza A; D'Angelo F; Del Giudice L; Fiorentini P; Marzano L; Nigro R; Sassone D; Torre P; Vicedomini D
G Ital Nefrol; 2023 Aug; 40(4):. PubMed ID: 37910214
[TBL] [Abstract][Full Text] [Related]
9. Euglycaemic diabetic ketoacidosis as a complication of SGLT-2 inhibitors: epidemiology, pathophysiology, and treatment.
Sampani E; Sarafidis P; Papagianni A
Expert Opin Drug Saf; 2020 Jun; 19(6):673-682. PubMed ID: 32521174
[TBL] [Abstract][Full Text] [Related]
10. Diabetic Ketoacidosis in Patients with Type 2 Diabetes on Sodium-Glucose Cotransporter-2 Inhibitors - A Case Series.
Sharma PV; Jobanputra YB; Lewin K; Bagatell S; Lichtstein DM
Rev Recent Clin Trials; 2018; 13(2):156-160. PubMed ID: 29542418
[TBL] [Abstract][Full Text] [Related]
11. Euglisemic diabetic ketoacidotic coma caused by dapagliflozin.
Karakaya Z; Topal FE; Topal F; Payza U; Akyol PY
Am J Emerg Med; 2018 Nov; 36(11):2136.e1-2136.e2. PubMed ID: 30150107
[TBL] [Abstract][Full Text] [Related]
12. ‘Euglycemic’ Ketoacidosis in a Patient With Type 2 Diabetes Being Treated With Canagliflozin.
Danford C; Chan P; Magill SB
WMJ; 2016 Aug; 115(4):206-9. PubMed ID: 29099159
[TBL] [Abstract][Full Text] [Related]
13. SGLT-2 inhibitor associated euglycaemic diabetic ketoacidosis in an orthopaedic trauma patient.
Ritchie DT; Dixon J
BMJ Case Rep; 2022 Sep; 15(9):. PubMed ID: 36113958
[TBL] [Abstract][Full Text] [Related]
14. Perioperative euglycemic diabetic ketoacidosis following use of SGLT-2 inhibitors after cardiac surgery.
Pontes JPJ; de Melo CS; Arantes FBB; de Souza Ramos JTG; Módolo NSP; Navarro E Lima LH
J Clin Anesth; 2021 Aug; 71():110201. PubMed ID: 33647525
[No Abstract] [Full Text] [Related]
15. EUGLYCEMIC DIABETIC KETOACIDOSIS AND SEVERE ACUTE KIDNEY INJURY SECONDARY TO OFF LABEL USE OF SODIUM GLUCOSE COTRANSPORTER-2 INHIBITOR IN A TYPE-1 DIABETIC PATIENT.
Tahir H; Wani A; Daruwalla V; Daboul N; Sagi J
J Ayub Med Coll Abbottabad; 2015; 27(4):923-4. PubMed ID: 27004352
[TBL] [Abstract][Full Text] [Related]
16. Hyperglycemic, high anion-gap metabolic acidosis in patients receiving SGLT-2 inhibitors for diabetes management.
Kum-Nji JS; Gosmanov AR; Steinberg H; Dagogo-Jack S
J Diabetes Complications; 2017 Mar; 31(3):611-614. PubMed ID: 27913012
[TBL] [Abstract][Full Text] [Related]
17. Euglycemic diabetic ketoacidosis associated with ST segment elevation myocardial infarction following SGLT-2 inhibitor therapy.
Baytuğan NZ; Çelik Aİ; Bezgin T; Çağdaş M
Am J Emerg Med; 2023 Sep; 71():250.e1-250.e3. PubMed ID: 37451968
[TBL] [Abstract][Full Text] [Related]
18. Sodium-glucose co-transporter type-2 inhibitors: pharmacology and peri-operative considerations.
Milder DA; Milder TY; Kam PCA
Anaesthesia; 2018 Aug; 73(8):1008-1018. PubMed ID: 29529345
[TBL] [Abstract][Full Text] [Related]
19. Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition.
Peters AL; Buschur EO; Buse JB; Cohan P; Diner JC; Hirsch IB
Diabetes Care; 2015 Sep; 38(9):1687-93. PubMed ID: 26078479
[TBL] [Abstract][Full Text] [Related]
20. [Perioperative Ketoacidosis under SGLT2-Inhibitors].
Buck S; Russo SG
Anasthesiol Intensivmed Notfallmed Schmerzther; 2021 Oct; 56(10):704-708. PubMed ID: 34704247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
